SP is indicated in Malaria-endemic areas in Africa, for Intermittent Preventive treatment of malaria in pregnancy for all women in their first or second pregnancy as part of antenatal care. In areas of moderate to high malaria transmission in Africa, for intermittent preventive treatment of malaria in infants (below 12 months of age) where SP is still effective.